Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer
Clinical trial NCT04487756 · COMPLETED
Trial details
- NCT number
- NCT04487756
- Sponsor
- Instituto Oncológico Dr Rosell
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-17
- Primary completion
- 2025-09-08
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.